NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/14/2020
Back to search
Official data from USPTO
ATRYN ANTITHROMBIN (RECOMBINANT)
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
02/27/2020
Trademark type
Combined
Nice classes
5
Filing date
04/14/2009
Registration date
02/16/2010
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/14/2020
Last transaction
02/27/2020
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/2009
First use in commerce
01/01/2009
Drawing code
3
Owner type
03
Owner location
FRAMINGHAM, MA, US
Examiner
MARTIN, EUGENIA K
Law office
M50
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of first line has the name "ATRYN" in dark blue with the "AT" being larger than the "RYN"; second line has "Antithrombin" in dark blue; third line has "Recombinant" in parenthesis in dark blue; beneath the "N" of "ATRYN", adjacent to lines two and three, is a representation of two plasmids resembling a figure "8". The overall color of the plasmids is green except that opposite sections of the plasmids appear in dark blue, representing the inserts.
Holders and representatives
Holders
REVO BIOLOGICS, INC.
LUNDBECK LLC
LUNDBECK INC.
LUNDBECK INC.
Representatives
Monte L. Falcoff/Jessica S. Sachs Harness, Dickey & Pierce, P.L.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders ; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardio-vascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemthe genitourinary system ; for the treatment of inflammatory disorders; for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders ; Pharmaceutical preparations for the treatment of antithrombin deficiency; Pharmaceutical preparationsanticoagulants
Publications
History of USPTO decisions and trademark events.
36 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/14/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/14/2020
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
02/14/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/03/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
11/15/2019
ES7R
TEAS SECTION 7 REQUEST RECEIVED
11/14/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
02/16/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
08/16/2016
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/16/2016
PR23
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
04/14/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/12/2016
E815
TEAS SECTION 8 & 15 RECEIVED
02/16/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/16/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/14/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/07/2013
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/07/2012
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/07/2011
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
02/16/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/01/2009
PUBO
PUBLISHED FOR OPPOSITION
12/01/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/29/2009
ALIE
ASSIGNED TO LIE
10/29/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/23/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/22/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/29/2009
GNRT
NON-FINAL ACTION E-MAILED
06/29/2009
CNRT
NON-FINAL ACTION WRITTEN
06/29/2009
DOCK
ASSIGNED TO EXAMINER
06/29/2009
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
04/18/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/17/2009
NWAP
NEW APPLICATION ENTERED
04/17/2009
Continuous trademark protection
Get notified about every new filing that threatens ATRYN ANTITHROMBIN (RECOMBINANT) or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.